drugset / Trial / NCT02529475

Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Healthy Subjects (HYDROPS)

NCT02529475

Phase 4 Terminated 25 enrolled University Hospital, Grenoble
NaSingle-groupOpen-labelDiagnostic

Summary

* This prospective study aims to better characterize inner ear's perilymphatic structures with Magnetic Resonance Imaging using contrast media and delayed injection in healthy subjects * MR Perfusion Imaging will be assess in both cochlea as well * Primary auditory brain pathways will be evaluated through MR diffusion imaging

Timeline

Start
2016-02-01
Primary completion
2020-09
Completion
2020-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Gadoteric acid Diagnostic / imaging agent 0.2 mmol

Indications